<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01599468</url>
  </required_header>
  <id_info>
    <org_study_id>TXA-1</org_study_id>
    <nct_id>NCT01599468</nct_id>
  </id_info>
  <brief_title>Can Tranexamic Acid Reduce Bleeding After Post Partum Hemorrhage in Cesarean Section Delivery</brief_title>
  <official_title>Effects of Tranexamic Acid on Post Partum Hemorrhage by Uterine Atony After Cesarean Section Delivery: a Randomized, Placebo Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hédi Chaker Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hédi Chaker Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to evaluate the effect of early administration of tranexamic
      acid (TXA) on post partum hemorrhage caused by uterine atony after cesarean section delivery.

      This was a randomised, placebo controlled trial including 74 patients. The investigators
      included ASA1 parturients with correct haemostatic status undergoing cesarean section under
      spinal anesthesia. The randomization begins after the inefficacy of oxytocin injections and
      starting up sulprostone perfusion at the request of the surgeon. TXA Group received 10 mg/kg
      of tranexamic acid as induction dose within 12 minutes and 1mg/Kg/h as maintenance within the
      2 following hours. Placebo Group received same volumes of normal saline. The investigators
      compared blood loss and transfusions in both groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>volume blood loss</measure>
    <time_frame>within 5 days after delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>transfusion rates.</measure>
    <time_frame>within 5 days after delivery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Post Partum Hemorrhage</condition>
  <arm_group>
    <arm_group_label>tranexamic acid, post partum hemorrhage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>10 mg/kg of tranexamic acid as induction dose within 12 minutes and 1mg/Kg/h as maintenance within the 2 following hours</description>
    <arm_group_label>tranexamic acid, post partum hemorrhage</arm_group_label>
    <other_name>exacyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline serum</intervention_name>
    <description>The Placebo group received normal saline with the same volumes</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>normal saline; NaCl 0.9%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA1 parturients

          -  aged from 20 to 40

          -  correct preoperative haemostatic status (prothrombine ratio &gt; 60 % and platelet rate &gt;
             100 000),

          -  cesarean section under spinal anesthesia complicated by uterine atony needing the
             introduction of Sulprostone

        Exclusion Criteria:

          -  abnormal placentation

          -  severe pre-eclampsia

          -  coagulopathy and uterine rupture

          -  the contra indications of TXA : past history of vascular occlusive event, convulsion,
             and allergy.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mohamed ayedi</last_name>
    <role>Principal Investigator</role>
    <affiliation>hedi chaker university hospital of sfax, tunisia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hedi Chaker University Hospital of Sfax, Department of Anesthesiology and Intensive Care</name>
      <address>
        <city>Sfax</city>
        <zip>3029</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <reference>
    <citation>Ducloy-Bouthors AS, Jude B, Duhamel A, Broisin F, Huissoud C, Keita-Meyer H, Mandelbrot L, Tillouche N, Fontaine S, Le Goueff F, Depret-Mosser S, Vallet B; EXADELI Study Group, Susen S. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15(2):R117. doi: 10.1186/cc10143. Epub 2011 Apr 15.</citation>
    <PMID>21496253</PMID>
  </reference>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 14, 2012</study_first_submitted>
  <study_first_submitted_qc>May 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2012</study_first_posted>
  <last_update_submitted>May 21, 2012</last_update_submitted>
  <last_update_submitted_qc>May 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hédi Chaker Hospital</investigator_affiliation>
    <investigator_full_name>mohamed ayedi</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>post partum hemorrhage</keyword>
  <keyword>transfusion</keyword>
  <keyword>tranexamic acid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Postpartum Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

